PMI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Picard Medical Inc (PMI) is not a good buy for a beginner, long-term investor with $50,000-$100,000 available for investment. The stock is currently embroiled in legal issues, has negative technical indicators, and lacks strong financial performance or positive catalysts to justify an investment. Additionally, there is no strong trading signal from Intellectia Proprietary Trading Signals to support a buy decision.
The technical indicators are bearish. The MACD histogram is negative and expanding downward, RSI indicates the stock is oversold at 19.86, and moving averages are bearish with SMA_200 > SMA_20 > SMA_5. The stock is trading near its support level (S1: 1.311), and the pre-market price is down 1.50%.
NULL identified.
The company is facing multiple class action lawsuits alleging fraudulent stock promotion schemes and securities fraud. This has caused significant financial instability and a drop in stock price. Gross margin has dropped significantly (-85.67% YoY), indicating operational inefficiency.
In Q3 2025, revenue increased by 34.73% YoY to $1,187,000, but the company remains unprofitable with a net income of -$10,426,000 (up 51.34% YoY). EPS improved to -0.14 (up 40% YoY), but gross margin dropped to -10.95%, a significant decline of -85.67% YoY.
No analyst rating or price target changes available.
